Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM598 in Patients With Rising PSA After Localized Prostate Cancer Therapy
NCT00050297Phase 2Terminated
- Sponsor
- Astellas Pharma
- Countries
- 7
01
Overview
Phase 2, randomised, double-blind trial of nebentan potassium in prostate cancer (PCa) (2 arms), sponsored by Astellas Pharma. Primary endpoint: Time to disease progression. Status: terminated.
02
Drugs
nebentan potassium
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00050297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050297.